- mehrmals pro WocheErscheinungsrhythmus
- 17 mintypische Länge
- vor 2 Tagenletzte Folge
Folgenzu den neuesten
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Aug. 3, 2026
本期播客内容来自《Scrip》杂志，精选内容涵盖截至2026年7月31日当周的生物制药行业的商业动态。本期节目采用人工智能文本转语音及语音仿真技术制作。 本期要闻: 阿斯利康收紧人工智能支出；Argenx的产品管线聚焦产品开发；葛兰素史克在推进III期临床试验计划的同时削减成本；赛诺菲对产品管线进行重新评估；以及中国业务新公司2.0版。 Story link: https://insights.citeline.com/scrip/podcasts/scrips-five-m
Scrip's Five Must-Know Things - Aug. 3, 2026
Audio roundup of selected biopharma industry content from Scrip over the business week ended July 31, 2026. This episode was produced with the help of AI text-to-voice and voice emulation tools. This time—AstraZeneca reins in AI spending; A
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) July 27, 2026
本期播客内容来自《Scrip》杂志，精选内容涵盖截至2026年7月24日当周的生物制药行业的商业动态。本期节目采用人工智能文本转语音及语音仿真技术制作。 本期要闻: 诺和诺德在肥胖症治疗领域起诉礼来；特朗普针对仿制药采取新的关税措施；诺华CEO称赞日本、抨击德国的定价政策；制药行业会迎来“稀土时刻”吗？；以及欧洲生物技术行业正处于十字路口。 Story/video links: https://insights.citeline.com/scrip/podcasts/scri
Scrip's Five Must-Know Things - July 27, 2026
Audio roundup of selected biopharma industry content from Scrip over the business week ended July 24, 2026. This episode was produced with the help of AI text-to-voice and voice emulation tools. This time—Novo Nordisk sues Lilly in obesity
European Biotech At A Crossroads: How Can It Stay Competitive? Video Podcast
This Scrip video podcast brings together three European biotech leaders to discuss the challenges facing the sector, and what measures are needed to stop it falling behind the US and China and to create the next generation of European biote
Scrip's Five Must-Know Things - July 21, 2026
Audio roundup of selected biopharma industry content from Scrip over the business week ended July 17, 2026. This episode was produced with the help of AI text-to-voice and voice emulation tools. This time—J&J ups guidance; Gilead’s acquisit
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) July 21, 2026
本期播客内容来自《Scrip》杂志，精选内容涵盖截至2026年7月17日当周的生物制药行业的商业动态。本期节目采用人工智能文本转语音及语音仿真技术制作。 本期要闻: 强生上调业绩预期；吉利德的收购策略；拜耳拆分传闻；百健的阿尔茨海默病研究结果；以及对礼来血液检测先驱的专访。 向听众们简要更新一下：Scrip现在已在Spotify (https://open.spotify.com/show/54Ki1l5bTzuxvrUylwbvO9?si=b282beb90fd244a1&
Alzheimer's AAIC Video Interview: Denali Therapeutics
Denali CEO Ryan Watts talks about the company's TransportVehicle platform and how it can open up delivery of a wide range of drug cargoes into the brain. Its first approved therapy is Avlayah for Hunter Syndrome, with tau and beta-amyloid t
Eisai Video Interview AT AAIC Alzheimer's Conference, July 15
Eisai's Michael Irizarry talks to Scrip about broadening Leqembi's use with its subcutaneous version, its ongoing Phase III in treating patients before dementia symptoms appear and news from a Phase II study of it tau-targeting asset, etala
Scrip Deals Podcast, July 2026, with Dr. Bruce Leuchter
On the July 2026 edition of the Scrip Deals Podcast, Scrip Senior Writer Joseph Haas and Bruce Leuchter, CEO of Neurvati Biosciences and GRIN Therapeutics, discussed the recent trend of biopharma M&A deals valued at $1bn or greater closing
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) July 13, 2026
本期播客内容来自《Scrip》杂志，精选内容涵盖截至2026年7月10日当周的生物制药行业的商业动态。本期节目采用人工智能文本转语音及语音仿真技术制作。 本期要闻: Vertex收购Crinetics；阿斯利康III期试验失败；强生公司的并购重点；伊普森（Ipsen）的“寻宝”之旅；以及Dyne首席执行官谈战略。 向听众们简要更新一下：Scrip现在已在Spotify (https://open.spotify.com/show/54Ki1l5bTzuxvrUylwbvO9?
Scrip's Five Must-Know Things - July 13, 2026
Audio roundup of selected biopharma industry content from Scrip over the business week ended July 10, 2026. This episode was produced with the help of AI text-to-voice and voice emulation tools. This time–Vertex's Crinetics deal; AstraZenec
Scrip's Five Must-Know Things - July 6, 2026
Audio roundup of selected biopharma industry content from Scrip over the business week ended July 3, 2026. This episode was produced with the help of AI text-to-voice and voice emulation tools. This time–later stage assets help fundraising;
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) July 6, 2026
本期播客内容来自《Scrip》杂志，精选内容涵盖截至2026年7月03日当周的生物制药行业的商业动态。本期节目采用人工智能文本转语音及语音仿真技术制作。 本期要闻: 后期阶段资产助力融资；今年并购活动激增；安进（Amgen）对 AI的策略；武田（Takeda）的AI战略；以及Anthropic推出Claude Science。 Story links: https://insights.citeline.com/scrip/podcasts/scrips-five-must-
Podcast: Europe’s Evolving Role in Global Clinical Trials
As global clinical development strategies evolve, Europe is emerging as a critical hub for scientific innovation, operational agility, and patient recruitment — reshaping its role in the future of clinical trials. In this episode, Scott Dav
Scrip Deals Podcast: An Interview With Jeremy Levin
Ovid Therapeutics Chairman Jeremy Levin talks with Scrip about how the US should view its biotech sector as a strategic national asset and urges the venture capital sector to place more emphasis on supporting early and innovative science.
